,,iv #aai? ,,congress #a/ ,session ,h4 ,,res4 #cfb ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,april #cj1 #bjbe,mr4 ,johnson ( ,georgia 7= himself1 ,ms4 ,velzquez1 ,ms4 ,williams ( ,georgia1 ,ms4 ,norton1 ,ms4 ,tokuda1 ,ms4 ,sewell1 & ,ms4 ,*u7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ,april #cj1 #bjbe1 z ,national ,adult ,hepatitis ,b ,vacc9ation ,aw>5ess ,day4 ,:]eas up to #b4d million individuals 9 ! ,unit$ ,/ates are *ronically infect$ ) hepatitis ,b1 & up to two-?irds ( individuals ) *ronic hepatitis ,b are unaw>e ( _! infection /atus2 ,:]eas hepatitis ,b is a viral infection ( ! liv] transmitt$ via infect$ blood & o!r body fluids1 includ+ ?r\gh "m-to-*ild transmission & injection drug use2 ,:]eas hepatitis ,b is associat$ ) significant disp>ities among communities ( color 7includ+ ,asian ,am]icans1 ,pacific ,isl&]s1 & ,african immigrants71 sexual & g5d] m9ority communities1 & ^? affect$ by ! opioid crisis2 ,:]eas individuals ) *ronic diseases su* z diabetes1 ,,hiv1 hepatitis ,c1 & *ronic liv] disease1 & individuals on hemodialysis are at an increas$ risk = hepatitis ,b co-infection2 ,:]eas !re is no cure = hepatitis ,b & individuals ) *ronic hepatitis ,b require lifelong m$ical c>e2 ,:]eas *ronic hepatitis ,b repres5ts "o ( ! mo/ common causes ( liv] canc]2 ,:]eas #a 9 e #d individuals ) unmanag$ *ronic hepatitis ,b w develop liv] canc]1 cirrhosis1 or liv] failure1 ) liv] canc] hav+ a #e-ye> survival rate ( only #ah p]c5t 9 ! ,unit$ ,/ates2 ,:]eas safe & highly effective vacc9es to protect aga9/ hepatitis ,b are available2 ,:]eas 9 accordance ) univ]sal *ildhood hepatitis ,b vacc9ation recomm5dations 9 ! ,unit$ ,/ates1 infants & *ildr5 h be5 r\t9ely vacc9at$ aga9/ hepatitis ,b s9ce ! #aiijs2 ,:]eas all adults ag$ #ai to #ei1 & adults #fj & old] ) hepatitis ,b risk factors1 are recomm5d$ to be vacc9at$ aga9/ hepatitis ,b2 ,:]eas ! hepatitis ,b vacc9e1 :i* is #ie p]c5t effective & 0 ! fir/ anticanc] vacc9e to be develop$1 is project$ to h prev5t$ #caj million cases ( hepatitis ,b worldwide f #aiij to #bjbj2 ,:]eas only #cj p]c5t ( adults 9 ! ,unit$ ,/ates are vacc9at$ aga9/ hepatitis ,b2 ,:]eas ! numb] ( report$ acute hepatitis ,b cases increas$ by #aa p]c5t nationwide betwe5 #bjad & #bjah2 ,:]eas1 z a result ( ! drug use epidemic1 !re h be5 significant regional increases 9 acute hepatitis ,b cases 9 ! ,unit$ ,/ates1 includ+-- 7#a7 a #dhi p]c5t increase 9 acute hepatitis ,b infections f #bjae to #bjaf 9 ,ma9e2 7#b7 a report$ #aad p]c5t increase f #bjji to #bjac 9 ,k5tucky1 ,we/ ,virg9ia1 & ,t5nessee2 7#c7 a report$ #gh p]c5t increase 9 #bjag 9 s\!a/]n ,massa*usetts2 & 7#d7 a report$ #ef p]c5t increase f #bjad to #bjaf 9 ,nor? ,c>ol9a2 ,:]eas #cf p]c5t ( new hepatitis ,b cases are among p :o inject drugs2 ,:]eas1 accord+ to ! ,c5t]s = ,disease ,control & ,prev5tion1 hepatitis ,b is #ej to #ajj times m infecti\s ?an ,,hiv & #e to #aj times m infecti\s ?an hepatitis ,c2 & ,:]eas !re are significant opportunities1 p>ticul>ly )9 ! sett+ ( ! drug use epidemic1 to prev5t new hepatitis ,b infections & !reby r$uce ! incid5ce ( liv] canc] & cirrhosis ?r\gh ef=ts to-- 7#a7 increase adult hepatitis ,b vacc9ation2 & 7#b7 ma9ta9 *ildhood hepatitis ,b vacc9ation3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,national ,adult ,hepatitis ,b ,vacc9ation ,aw>5ess ,day2 7#b7 recognizes ! importance ( provid+ support & enc\ragem5t-- 7,a7 = all adults ag$ #ah & old] to be te/$ = hepatitis ,b at lea/ once 9 _! lifetime 9 accordance ) recomm5dations2 7,b7 = individuals susceptible to infection to be vacc9at$ aga9/ hepatitis ,b2 & 7,c7 = individuals diagnos$ ) hepatitis ,b to be l9k$ to appropriate c>e2 & 7#c7 9 ord] to r$uce ! numb] ( new hepatitis ,b infections & hepatitis ,b-relat$ dea?s1 enc\rages a commitm5t to-- 7,a7 increas+ adult hepatitis ,b vacc9ation rates2 7,b7 ma9ta9+ *ildhood hepatitis ,b vacc9ation rates2 & 7,c7 promot+ provid] & community aw>5ess ( adult hepatitis ,b vacc9ation4